136
Views
28
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Fecal pyruvate kinase: A potential new marker for intestinal inflammation in children with inflammatory bowel disease

, , , , , , , , , , , & , MD show all
Pages 1147-1150 | Received 10 Jan 2007, Published online: 08 Jul 2009

References

  • Dubinsky MC, Ofman JJ, Urman M, Targan SR, Seidman EG. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001; 96: 758–65
  • Adeyem BO, Hodgson HJF. Faecal elastase reflects disease activity in active ulcerative colitis. Scand J Gastroenterol. 1992; 27: 139–42
  • Uchida K, Matsuse R, Tomita S, Sugi K, Saitoh O, Ohshiba S. Immunochemical detection of human lactoferrin in faeces as a new marker of inflammatory gastrointestinal disorders and colon cancer. Clin Biochem 1994; 27: 259–64
  • Bunn SK, Bisset WM, Main MJC, Golden BE. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001; 32: 171–7
  • Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli P, Arpe P, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liv Dis 2003; 35: 642–7
  • Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003; 98: 1309–14
  • Walkowiak J, Banasiewicz T, Krokowicz P, Hansdorfer-Korzon R, Drews M, Herzig K-H. Fecal pyruvate kinase (M2-PK): A new predictor for inflammation and severity of pouchitis. Scand J Gastroenterol 2005; 40: 1493–4
  • Kechemir D, Max-Audit I, Calvin-Preval MC, Rosa R. Purification of human leucocytes pyruvate kinase. J Chromatogr 1986; 343: 43
  • McDowell G, Gupta S, Dellerba M, Coppinger T, Levy RD, Keevil BG. Plasma concentrations of tumour dimeric pyruvate kinase are increased in patients with chronic cardiac failure. Ann Clin Biochem 2004; 41: 491–3
  • Oehler R, Weingartmann G, Manhart N, Salzer U, Meissner M, Schlegel W, et al. Polytrauma induces increased expression of pyruvate kinase in neutrophils. Blood 2000; 95: 1086–92
  • Hardt PD, Mazurek S, Toepler M, Schlierbach P, Bretzel RG, Eigenbrodt E, et al. Faecal tumour M2 pyruvate kinase: a new, sensitive screening tool for colorectal cancer. Br J Cancer 2004; 91: 980–4
  • Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991; 12: 439–47
  • Mahadevan U, Loftus EV, Jr, Tremaine WJ, Pemberton JH, Harmsen WS, Schleck CD, et al. Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications. Inflamm Bowel Dis 2002; 8: 311–6
  • Zhang B, Chen DD, Wang GB, Shen P. Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls. World J Gastroenterol 2004; 10: 1643–6
  • Ventrucci M, Cipolla A, Racchini C, Casadei R, Simoni P, Gullo L. Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer. Dig Dis Sci 2004; 49: 1149–55

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.